Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT01961115Phase 2Completed
Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma
Mucosal MelanomaRecurrent MelanomaRecurrent Uveal Melanoma+8 more
PrincipalinvestigatorStart date: 2013-09-13

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Joseph Skitzki

Roswell Park Cancer Institute

Related
3 trials

Shared therapeutic areas:

Stage IIIA Skin MelanomaStage IIIB Skin MelanomaStage IIIC Skin Melanoma+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score14%

Kunle Odunsi

Roswell Park Cancer Institute

Related
5 trials

Shared therapeutic areas:

Recurrent MelanomaStage IIIA Skin MelanomaStage IIIB Skin Melanoma+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score14%

Sharon Manne

Rutgers Cancer Institute of New Jersey

Related
5 trials

Shared therapeutic areas:

Stage IIIA Skin MelanomaStage IIIB Skin MelanomaStage IIIC Skin Melanoma+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score11%

Paul Chapman

Memorial Sloan Kettering Cancer Center

Related
3 trials

Shared therapeutic areas:

Recurrent MelanomaRecurrent Uveal MelanomaStage IV Skin Melanoma+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score11%

Mitchell Kamrava

Jonsson Comprehensive Cancer Center

Related
2 trials

Shared therapeutic areas:

Stage IIIA Uveal MelanomaStage IIIB Uveal MelanomaStage IIIC Uveal Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Gregory Daniels, MD, PhD

University of California, San Diego

Related
2 trials

Shared therapeutic areas:

Stage IIIB Skin MelanomaStage IIIC Skin Melanoma
Similarity Score5%

Muralidhar Beeram

Cancer Therapy and Research Center at The UT Health Science Center at San Antonio

Related
3 trials

Shared therapeutic areas:

Recurrent MelanomaStage IV Skin Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Jeffrey Weber

University of Southern California

Related
4 trials

Shared therapeutic areas:

Recurrent MelanomaMucosal Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Mohammad K. Khan, MD, PhD

Emory University

Related
3 trials

Shared therapeutic areas:

Mucosal MelanomaStage IV Skin Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Thomas Gajewski

University of Chicago Comprehensive Cancer Center

Related
3 trials

Shared therapeutic areas:

Recurrent MelanomaStage IV Skin Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT01961115Phase 2PrincipalInvestigator

Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma

Mucosal MelanomaRecurrent MelanomaRecurrent Uveal Melanoma+8 more
Completed

All 1 trials loaded